Related Experiment Video
Updated: Jan 22, 2026

Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction
Published on: February 24, 2014
Development of Streptococcus pneumoniae Pan-Group Quorum-Sensing Modulators.
Bimal Koirala1, Yftah Tal-Gan1
1Department of Chemistry, University of Nevada, Reno, 1664 North Virginia Street, Reno, NV, 89557, USA.
Scientists developed novel peptide-based molecules that can activate or inhibit quorum sensing (QS) in Streptococcus pneumoniae. These compounds offer a promising strategy for developing new anti-virulence therapies against drug-resistant bacterial infections.
Area of Science:
- Microbiology
- Drug Discovery
- Molecular Biology
Background:
- Multidrug-resistant pathogens, like Streptococcus pneumoniae, pose a significant global health threat.
- Streptococcus pneumoniae causes severe diseases and rapidly develops antibiotic resistance.
- Bacterial communication, or quorum sensing (QS), regulates virulence in S. pneumoniae.
Purpose of the Study:
- To design novel signal-based quorum sensing (QS) modulators targeting Streptococcus pneumoniae.
- To develop compounds effective against the two main QS specificity groups within S. pneumoniae.
Main Methods:
- Systematic analysis and rational design of peptide-based molecules.
- Construction and testing of QS activators and inhibitors.
- Evaluation of compound activity in the nanomolar range.
Main Results:
- Successfully designed peptide-based pan-group QS activators and inhibitors.
- Achieved high potency with activities in the nanomolar range.
- Identified privileged scaffolds for therapeutic development.
Conclusions:
- Developed novel QS modulators for Streptococcus pneumoniae.
- These compounds represent a promising avenue for anti-virulence drug development.
- Offers a potential strategy to combat antibiotic resistance in S. pneumoniae infections.
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
The Sense of Self: Reflected Self-Appraisal and Social Comparison
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Introduction to Special Senses

